Skip to main content
Top
Published in: BMC Public Health 1/2012

Open Access 01-12-2012 | Research article

The Cedar Project: high incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities

Authors: Patricia M Spittal, Margo E Pearce, Negar Chavoshi, Wayne M Christian, Akm Moniruzzaman, Mary Teegee, Martin T Schechter

Published in: BMC Public Health | Issue 1/2012

Login to get access

Abstract

Background

Factors associated with HCV incidence among young Aboriginal people in Canada are still not well understood. We sought to estimate time to HCV infection and the relative hazard of risk factors associated HCV infection among young Aboriginal people who use injection drugs in two Canadian cities.

Methods

The Cedar Project is a prospective cohort study involving young Aboriginal people in Vancouver and Prince George, British Columbia, who use illicit drugs. Participants’ venous blood samples were drawn and tested for HCV antibodies. Analysis was restricted to participants who use used injection drugs at enrolment or any of follow up visit. Cox proportional hazards regression was used to identify independent predictors of time to HCV seroconversion.

Results

In total, 45 out of 148 participants seroconverted over the study period. Incidence of HCV infection was 26.3 per 100 person-years (95% Confidence Interval [CI]: 16.3, 46.1) among participants who reported using injection drugs for two years or less, 14.4 per 100 person-years (95% CI: 7.7, 28.9) among participants who had been using injection drugs for between two and five years, and 5.1 per 100 person-years (95% CI: 2.6,10.9) among participants who had been using injection drugs for over five years. Independent associations with HCV seroconversion were involvement in sex work in the last six months (Adjusted Hazard Ratio (AHR): 1.59; 95% CI: 1.05, 2.42) compared to no involvement, having been using injection drugs for less than two years (AHR: 4.14; 95% CI: 1.91, 8.94) and for between two and five years (AHR: 2.12; 95%CI: 0.94, 4.77) compared to over five years, daily cocaine injection in the last six months (AHR: 2.47; 95% CI: 1.51, 4.05) compared to less than daily, and sharing intravenous needles in the last six months (AHR: 2.56; 95% CI: 1.47, 4.49) compared to not sharing.

Conclusions

This study contributes to the limited body of research addressing HCV infection among Aboriginal people in Canada. The HCV incidence rate among Cedar Project participants who were new initiates of injection drug use underscores an urgent need for HCV and injection prevention and safety strategies aimed at supporting young people surviving injection drug use and sex work in both cities. Young people must be afforded the opportunity to provide leadership and input in the development of prevention programming.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hansen D: Hep C cases linked to residential schools. 2010, Vancouver: Vancouver Sun, B2-B2 Hansen D: Hep C cases linked to residential schools. 2010, Vancouver: Vancouver Sun, B2-B2
2.
go back to reference Ko HH, et al: Liver disease in the indigenous populations of the Arctic, sub-Arctic, and Pacific Northwest. BC Med J. 2006, 48: 216-221. Ko HH, et al: Liver disease in the indigenous populations of the Arctic, sub-Arctic, and Pacific Northwest. BC Med J. 2006, 48: 216-221.
3.
go back to reference Wong T, Lee SS: Hepatitis C: a review for primary care physicians. CMAJ Can Med Assoc J: J l'Assoc Med Can. 2006, 174: 649-659. 10.1503/cmaj.1030034.CrossRef Wong T, Lee SS: Hepatitis C: a review for primary care physicians. CMAJ Can Med Assoc J: J l'Assoc Med Can. 2006, 174: 649-659. 10.1503/cmaj.1030034.CrossRef
4.
go back to reference Cooper CL: Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians. Can J Gastroenterol J Can Gastroenterol. 2008, 22: 677-680.CrossRef Cooper CL: Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians. Can J Gastroenterol J Can Gastroenterol. 2008, 22: 677-680.CrossRef
5.
go back to reference Buxton JA, et al: HCV co-infection in HIV positive population in British Columbia, Canada. BMC Publ Health. 2010, 10: 225-225. 10.1186/1471-2458-10-225.CrossRef Buxton JA, et al: HCV co-infection in HIV positive population in British Columbia, Canada. BMC Publ Health. 2010, 10: 225-225. 10.1186/1471-2458-10-225.CrossRef
6.
go back to reference Miller CL, et al: HIV and hepatitis C outbreaks among high-risk youth in Vancouver demands a public health response. Can J Public Health. 2005, 96: 107-108.PubMed Miller CL, et al: HIV and hepatitis C outbreaks among high-risk youth in Vancouver demands a public health response. Can J Public Health. 2005, 96: 107-108.PubMed
7.
go back to reference Fischer B, Haydon E, Rehm J, Krajden M, Reimer J: Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada. J Urban Health Bull N Y Acad Med. 2004, 81: 428-447. 10.1093/jurban/jth128.CrossRef Fischer B, Haydon E, Rehm J, Krajden M, Reimer J: Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada. J Urban Health Bull N Y Acad Med. 2004, 81: 428-447. 10.1093/jurban/jth128.CrossRef
8.
go back to reference Public Health Agency of Canada: Epi-Update: Hepatitis C virus (HCV) among Aboriginal people surveyed by three national enhanced surveillance systems in Canada. 2010, Ottawa: Centre for Communicable Disease and Infection Control Public Health Agency of Canada: Epi-Update: Hepatitis C virus (HCV) among Aboriginal people surveyed by three national enhanced surveillance systems in Canada. 2010, Ottawa: Centre for Communicable Disease and Infection Control
9.
go back to reference Miller CL, et al: Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002, 36: 737-742. 10.1053/jhep.2002.35065.CrossRefPubMed Miller CL, et al: Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002, 36: 737-742. 10.1053/jhep.2002.35065.CrossRefPubMed
10.
go back to reference Roy E, Boudreau J-F, Boivin J-F: Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience. Drug Alcohol Depend. 2009, 102: 158-161. 10.1016/j.drugalcdep.2009.01.006.CrossRefPubMed Roy E, Boudreau J-F, Boivin J-F: Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience. Drug Alcohol Depend. 2009, 102: 158-161. 10.1016/j.drugalcdep.2009.01.006.CrossRefPubMed
11.
go back to reference Miller CL, et al: The Cedar Project: risk factors for transition to injection drug use among young, urban Aboriginal people. Can Med Assoc J. 2011, 183: 1147-1154. 10.1503/cmaj.101257.CrossRef Miller CL, et al: The Cedar Project: risk factors for transition to injection drug use among young, urban Aboriginal people. Can Med Assoc J. 2011, 183: 1147-1154. 10.1503/cmaj.101257.CrossRef
12.
go back to reference Roy E, Boudreau JF, Leclerc P, Boivin JF, Godin G: Trends in injection drug use behaviours over 10 years among street youth. Drug Alcohol Depend. 2007, 89: 170-175. 10.1016/j.drugalcdep.2006.12.025.CrossRefPubMed Roy E, Boudreau JF, Leclerc P, Boivin JF, Godin G: Trends in injection drug use behaviours over 10 years among street youth. Drug Alcohol Depend. 2007, 89: 170-175. 10.1016/j.drugalcdep.2006.12.025.CrossRefPubMed
13.
go back to reference Spittal PM, et al: The Cedar Project: Prevalence and Correlates of HIV Infection among Young Aboriginal People who use Drugs in Two Canadian Cities. Int J Circumpolar Health. 2007, 66: 225-240.CrossRef Spittal PM, et al: The Cedar Project: Prevalence and Correlates of HIV Infection among Young Aboriginal People who use Drugs in Two Canadian Cities. Int J Circumpolar Health. 2007, 66: 225-240.CrossRef
14.
go back to reference Patrick DM, et al: Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. Can Med Assoc J. 2001, 165: 889-895. Patrick DM, et al: Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. Can Med Assoc J. 2001, 165: 889-895.
15.
go back to reference Clatts MC, Colón-López V, Giang LM, Goldsamt LA: Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. J Urban Health Bull N Y Acad Med. 2010, 87: 278-291. 10.1007/s11524-009-9417-9.CrossRef Clatts MC, Colón-López V, Giang LM, Goldsamt LA: Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. J Urban Health Bull N Y Acad Med. 2010, 87: 278-291. 10.1007/s11524-009-9417-9.CrossRef
16.
go back to reference Maher L, et al: Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction. 2006, 101: 1499-1508. 10.1111/j.1360-0443.2006.01543.x.CrossRefPubMed Maher L, et al: Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction. 2006, 101: 1499-1508. 10.1111/j.1360-0443.2006.01543.x.CrossRefPubMed
17.
go back to reference Tyndall MW, et al: Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS (London, England). 2003, 17: 887-893. 10.1097/00002030-200304110-00014.CrossRef Tyndall MW, et al: Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS (London, England). 2003, 17: 887-893. 10.1097/00002030-200304110-00014.CrossRef
18.
go back to reference Craib K, Spittal PM, Patel SH, Christian WM, Moniruzzaman A, Pearce ME, Pearce ME, Demerais L, Sherlock C, Schechter M, For the Cedar Project Partnership: Prevalence and incidence of hepatitis C virus infection among Aboriginal young people who use drugs: results from the Cedar Project. Open Med. 2009, 3: 220-227. Craib K, Spittal PM, Patel SH, Christian WM, Moniruzzaman A, Pearce ME, Pearce ME, Demerais L, Sherlock C, Schechter M, For the Cedar Project Partnership: Prevalence and incidence of hepatitis C virus infection among Aboriginal young people who use drugs: results from the Cedar Project. Open Med. 2009, 3: 220-227.
19.
go back to reference Browne AJ: Discourses influencing nurses' perceptions of First Nations patients. Can J Nur Res Rev Can Rech Sci Infirmieres. 2005, 37: 62-87. Browne AJ: Discourses influencing nurses' perceptions of First Nations patients. Can J Nur Res Rev Can Rech Sci Infirmieres. 2005, 37: 62-87.
20.
go back to reference Tousignant M, Sioui N: Resilience and Aboriginal Communities in Crisis: Theory and Interventions. J Aboriginal Health. 2009, November: 43-61. Tousignant M, Sioui N: Resilience and Aboriginal Communities in Crisis: Theory and Interventions. J Aboriginal Health. 2009, November: 43-61.
21.
22.
go back to reference Mehrabadi A, Craib KJ, Patterson K, Adam W, Moniruzzaman A, Ward-Burkitt B, Schechter MT, Spittal PM, for the Cedar Project Partnership: The Cedar Project: a comparison of HIV-related vulnerabilities amongst young Aboriginal women surviving drug use and sex work in two Canadian cities. Int J Drug Policy. 2008, 19: 159-168. 10.1016/j.drugpo.2007.07.005.CrossRefPubMed Mehrabadi A, Craib KJ, Patterson K, Adam W, Moniruzzaman A, Ward-Burkitt B, Schechter MT, Spittal PM, for the Cedar Project Partnership: The Cedar Project: a comparison of HIV-related vulnerabilities amongst young Aboriginal women surviving drug use and sex work in two Canadian cities. Int J Drug Policy. 2008, 19: 159-168. 10.1016/j.drugpo.2007.07.005.CrossRefPubMed
23.
go back to reference Spittal PM, et al: Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. AIDS Care. 2003, 15: 187-195. 10.1080/0954012031000068335.CrossRefPubMed Spittal PM, et al: Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. AIDS Care. 2003, 15: 187-195. 10.1080/0954012031000068335.CrossRefPubMed
24.
go back to reference Shannon K, et al: Survival sex work involvement as a primary risk factor for hepatitis C virus acquisition in drug-using youths in a canadian setting. Arch Pediatr Adolesc Med. 2010, 164: 61-65. 10.1001/archpediatrics.2009.241.CrossRefPubMedPubMedCentral Shannon K, et al: Survival sex work involvement as a primary risk factor for hepatitis C virus acquisition in drug-using youths in a canadian setting. Arch Pediatr Adolesc Med. 2010, 164: 61-65. 10.1001/archpediatrics.2009.241.CrossRefPubMedPubMedCentral
25.
go back to reference Romero-Daza N, Weeks M, Singer M: "Nobody gives a damn if I live or die": violence, drugs, and street-level prostitution in inner-city Hartford, Connecticut. Med Anthropol. 2003, 22: 233-259. 10.1080/01459740306770.CrossRefPubMed Romero-Daza N, Weeks M, Singer M: "Nobody gives a damn if I live or die": violence, drugs, and street-level prostitution in inner-city Hartford, Connecticut. Med Anthropol. 2003, 22: 233-259. 10.1080/01459740306770.CrossRefPubMed
26.
go back to reference Evans-Campbell T, Lindhorst T, Huang B, Walters KL: Interpersonal violence in the lives of urban American Indian and Alaska Native women: implications for health, mental health, and help-seeking. Am J Public Health. 2006, 96: 1416-1422. 10.2105/AJPH.2004.054213.CrossRefPubMedPubMedCentral Evans-Campbell T, Lindhorst T, Huang B, Walters KL: Interpersonal violence in the lives of urban American Indian and Alaska Native women: implications for health, mental health, and help-seeking. Am J Public Health. 2006, 96: 1416-1422. 10.2105/AJPH.2004.054213.CrossRefPubMedPubMedCentral
27.
go back to reference Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D: Correlates of HIV infection among young adult short-term injection drug users. AIDS (London, England). 2000, 14: 717-726. 10.1097/00002030-200004140-00011.CrossRef Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D: Correlates of HIV infection among young adult short-term injection drug users. AIDS (London, England). 2000, 14: 717-726. 10.1097/00002030-200004140-00011.CrossRef
28.
go back to reference Miller CL, et al: Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr. 2002, 30: 335-341.CrossRefPubMed Miller CL, et al: Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr. 2002, 30: 335-341.CrossRefPubMed
29.
go back to reference Canada (Attorney General): Canada (Attorney General) v. PHS Community Services Society. 2011, Ottawa: Supreme Court of Canada Canada (Attorney General): Canada (Attorney General) v. PHS Community Services Society. 2011, Ottawa: Supreme Court of Canada
30.
go back to reference Makin K, Dhillon S, Perez I: Supreme Court ruling opens doors to drug injection clinics across Canada. 2011, Ottawa: The Globe & Mail Makin K, Dhillon S, Perez I: Supreme Court ruling opens doors to drug injection clinics across Canada. 2011, Ottawa: The Globe & Mail
31.
go back to reference Moniruzzaman A, Patel SH, Miller C, Bingham B, Spittal PM: The Cedar Project: Factors associated with using Vancouver’s Safe Injection Site among young Aboriginal people who use injection drugs. 2010, Toronto: Canadian Public Health Association Annual Conference, Oral presentation Moniruzzaman A, Patel SH, Miller C, Bingham B, Spittal PM: The Cedar Project: Factors associated with using Vancouver’s Safe Injection Site among young Aboriginal people who use injection drugs. 2010, Toronto: Canadian Public Health Association Annual Conference, Oral presentation
32.
go back to reference Browne AJ: Clinical Encounters Between Nurses and First Nations Women in A Western Canadian Hospital. Soc Sci Med. 2007, 64: 2167-2176.CrossRef Browne AJ: Clinical Encounters Between Nurses and First Nations Women in A Western Canadian Hospital. Soc Sci Med. 2007, 64: 2167-2176.CrossRef
33.
go back to reference Dell CA, Lyons T: Harm Reduction Policies and Programs for Persons of Aboriginal Descent. 2007, Ottawa, Ontario: Canadian Centre on Substance Abuse Dell CA, Lyons T: Harm Reduction Policies and Programs for Persons of Aboriginal Descent. 2007, Ottawa, Ontario: Canadian Centre on Substance Abuse
34.
go back to reference Harris R, et al: Effects of self-reported racial discrimination and deprivation on Māori health and inequalities in New Zealand: cross-sectional study. Lancet. 2006, 367: 2005-2009. 10.1016/s0140-6736(06)68890-9.CrossRefPubMed Harris R, et al: Effects of self-reported racial discrimination and deprivation on Māori health and inequalities in New Zealand: cross-sectional study. Lancet. 2006, 367: 2005-2009. 10.1016/s0140-6736(06)68890-9.CrossRefPubMed
35.
go back to reference Smye V, Browne AJ: 'Cultural safety' and the analysis of health policy affecting aboriginal people. Nurs Res. 2002, 9: 42-56. Smye V, Browne AJ: 'Cultural safety' and the analysis of health policy affecting aboriginal people. Nurs Res. 2002, 9: 42-56.
36.
go back to reference Iverson J, Wand H, Gonnermann A, Maher L: Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998–2008. Int J Drug Policy. 2010, 21: 471-476. 10.1016/j.drugpo.2010.04.004.CrossRef Iverson J, Wand H, Gonnermann A, Maher L: Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998–2008. Int J Drug Policy. 2010, 21: 471-476. 10.1016/j.drugpo.2010.04.004.CrossRef
Metadata
Title
The Cedar Project: high incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities
Authors
Patricia M Spittal
Margo E Pearce
Negar Chavoshi
Wayne M Christian
Akm Moniruzzaman
Mary Teegee
Martin T Schechter
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2012
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-12-632

Other articles of this Issue 1/2012

BMC Public Health 1/2012 Go to the issue